Improving the Outcomes of Children With Tuberculosis Through Innovative Diagnostics and Treatment Monitoring

This study aims at identifying and evaluating novel diagnostic methods for children evaluated for respiratory tuberculosis. The investigators will use alternative samples like stool, urine, and masks to diagnose children with respiratory tuberculosis. Once diagnosed, the investigators will use target next generation sequencing to determine if the bacillus is resistant to any of the drugs used for treatment. Additionally, children initiated under TB treatment will be followed-up during treatment to measure blood biomarkers for outcome prediction. Finally, spirometry will be performed longitudinally until 3 months after the end of treatment to assess the lung capacity of children treated for respiratory TB. All children initiated on TB treatment will fill in a quality of life questionnaire.

NCT Number	NCT06815588
Lead Sponsor	Research Center Borstel Collaborators: LMU Klinikum
Conditions	Tuberculosis
Enrollment	100 participants
Start Date	2024-09-15
Primary Completion	2025-12-31 (estimated)
Study Completion	2026-03-30 (estimated)
Updated on ClinicalTrials.gov	2025-02-07